T.A. Luger

524 total citations
14 papers, 347 citations indexed

About

T.A. Luger is a scholar working on Dermatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, T.A. Luger has authored 14 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 5 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in T.A. Luger's work include Cutaneous lymphoproliferative disorders research (4 papers), Autoimmune Bullous Skin Diseases (3 papers) and Mast cells and histamine (3 papers). T.A. Luger is often cited by papers focused on Cutaneous lymphoproliferative disorders research (4 papers), Autoimmune Bullous Skin Diseases (3 papers) and Mast cells and histamine (3 papers). T.A. Luger collaborates with scholars based in Germany, Austria and United States. T.A. Luger's co-authors include B. M. Henz, Wolfram Sterry, R Stadler, T. Zwingers, Dieter Metze, G. Kolde, Eggert Stockfleth, Clemens Sorg, Cord Sunderkötter and E. C. Foerster and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and British Journal of Dermatology.

In The Last Decade

T.A. Luger

14 papers receiving 332 citations

Peers

T.A. Luger

DERMA

PFM

EPIDE

IMMUN

RHEUM

J L Verret France

P. Duhra United Kingdom

P.H. CARTWRIGHT United Kingdom

Irina Turchin Canada

John L. Aeling United States

MA Gürer Türkiye

Yavuz Harmanyeri Türkiye

Neetu Bhari India

Emin Özlü Türkiye

S. Pérez‐Gala Spain

J L Verret France

T.A. Luger

157 ×0.8

DERMA

92 ×0.6

PFM

114 ×1.0

EPIDE

65 ×0.6

IMMUN

47 ×0.8

RHEUM

Citations per year, relative to T.A. Luger T.A. Luger (= 1×) peers J L Verret

Countries citing papers authored by T.A. Luger

Since Specialization

Citations

This map shows the geographic impact of T.A. Luger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.A. Luger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.A. Luger more than expected).

Fields of papers citing papers by T.A. Luger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.A. Luger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.A. Luger. The network helps show where T.A. Luger may publish in the future.

Co-authorship network of co-authors of T.A. Luger

This figure shows the co-authorship network connecting the top 25 collaborators of T.A. Luger. A scholar is included among the top collaborators of T.A. Luger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.A. Luger. T.A. Luger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Böhm, Markus, M. Schiller, & T.A. Luger. (2006). Non-pigmentary actions of alpha-melanocyte-stimulating hormone--lessons from the cutaneous melanocortin system.. PubMed. 52(2). 61–8. 13 indexed citations

2.

Bohmeyer, Jörg, Rudolf Stadler, D. Nashan, et al.. (2003). Bexarotene – an alternative therapy for progressive cutaneous T‐cell lymphoma? First experiences. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 1(10). 785–789. 5 indexed citations

3.

Ständer, Hartmut, Sonja Ständer, T.A. Luger, & Th. Schwarz. (2001). Topisches Interferon-β. Der Hautarzt. 52(10). 882–884. 1 indexed citations

4.

Metze, Dieter, et al.. (2001). Successful topical treatment of focal epithelial hyperplasia (Heck's disease) with interferon-beta. British Journal of Dermatology. 144(5). 1067–1069. 31 indexed citations

5.

Luger, T.A., et al.. (2001). Imiquimod - eine neue Therapiemöglichkeit der bowenoiden Papulose?. Der Hautarzt. 52(2). 128–131. 11 indexed citations

6.

Nashan, D. & T.A. Luger. (2001). Zytokine. Der Hautarzt. 52(8). 691–696. 3 indexed citations

7.

Artuc, Metin, Andreas Grützkau, T.A. Luger, & B. M. Henz. (1999). Expression of MC1‐ and MC5‐Receptors on the Human Mast Cell Line HMC‐1. Annals of the New York Academy of Sciences. 885(1). 364–367. 14 indexed citations

8.

Brehler, R., et al.. (1999). <i>Helicobacter pylori </i>as a Possible Bacterial Focus of Chronic Urticaria. Dermatology. 198(2). 130–132. 37 indexed citations

9.

Luger, T.A.. (1999). Immunomodulation by UV light: role of neuropeptides.. PubMed. 8(3). 198–9. 7 indexed citations

10.

Stadler, R, et al.. (1998). Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.. Blood. 92(10). 3578–81. 154 indexed citations

11.

Kolde, G., T.A. Luger, Clemens Sorg, & Cord Sunderkötter. (1996). Successful Treatment of Cutaneous Leishmaniasis Using Systemic Interferon-Gamma. Dermatology. 192(1). 56–60. 23 indexed citations

12.

Mohr, Charles, et al.. (1995). Eosinophilic Pustular Folliculitis: Successful Treatment with Interferon-Alpha. Dermatology. 191(3). 257–259. 15 indexed citations

13.

Gisslinger, Heinz, Otto C. Burghuber, G. Stacher, et al.. (1991). Efficacy of cyclosporin A in systemic sclerosis.. PubMed. 9(4). 383–90. 30 indexed citations

14.

Luger, T.A., et al.. (1989). Das Verhalten von hGH (Wachstumshormon, Human Growth Hormone) und Somatomedin C nach Narkoseeinleitung mit Propofol im Vergleich zu Diazepam und Thiopental. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 24(4). 226–230. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact